PhD MD TRR219-associated students

Pascal Mann

 

PhD student

University Hospital RWTH Aachen

Department of Cardiology, Medical Clinic I

 

Project: The SGLT2 inhibitor ertugliflozin reduces cardiac fibrosis and modulates cardiac substrate metabolism in a mouse model of cardiac hypertrophy

PI: Michael Lehrke

 

SGLT2 inhibitors reduced heart failure hospitalization in patients with and without diabetes. SGLT2 inhibitors prevent the reabsorption of primarily filtered glucose in the proximal renal tubulus leading to increased urinary glucose excretion and osmotic diuresis. The aim of the project is the investigation of the underlying cardioprotective effects. 

© 2021 - University Hospital RWTH Aachen